As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The global immunomodulators market attained a value of about USD 175 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 5.8% to reach nearly USD 245 billion by 2026.
North America is a significant market for the global immunomodulatory industry because of the growing geriatric population in this region. Due to the surging incidence of chronic diseases like sclerosis, Crohn’s disease, ulcerative colitis in the United States, demand from end-users for immunomodulator-based treatment and the high therapy cost associated with the treatment of sclerosis are anticipated to drive revenue growth in this segment.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Further, awareness among the masses and government initiatives are also boosting the immunomodulator industry. Europe, on the other hand, is expected to witness substantial growth backed by the increasing sales of immunosuppressant products in the region.
COVID-19 has shown its footprint across the globe, severely affecting many economies and industries due to lockdowns and several restrictions. However, coronavirus has positively affected the immunomodulator industry, owing to rise in the sales of products with respect to the emergency. Various pharmaceutical companies are trying to balance demand and supply to keep their sales flow smooth. These pharmaceutical companies are now trying to invest more in quality control, strengthen their research and development departments, and magnify supply chain management, which is expected to boost the market growth over the forecast period.
Immunomodulators are substances that are used to regulate or normalise the immunity system. It supports immune function by modifying, generally in a healthy way, the immune system’s response to a threat. They are directed to enhance the immune response against infectious diseases, tumours, primary or secondary immunodeficiency, and alterations in antibody transfer, among others.
The major types of immunomodulators on the basis of product are:
The market can be broadly categorised on the basis of its applications into:
The EMR report looks into the regional markets of immunomodulators like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The key contributory factor in the growth of the global immunomodulators industry is the increasing incidence of chronic diseases, including asthma, allergic conditions, cancer, and multiple sclerosis. Further, some of the factors contributing to the growth of the immunomodulator industry include the prevailing cases of organ transplantation, increasing adoption of an early immunomodulator therapy for the Crohn’s disease treatment, rising awareness about inflammatory bowel diseases, growing autoimmune diseases, and increasing development of drug resistance, which is resulting in the rise of immunomodulators usage.
However, the market growth may hinder due to the presence of stringent regulatory approval procedures, along with the high cost of the therapy and the immunomodulator products. Further, adverse effects of immunomodulatory drugs, such as pain, inflammation, epilepsy, are likely to restrain the market growth during the forecast period.
The report presents a detailed analysis of the following key players in the global immunomodulators market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
|Scope of the Report||Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, Region|
|Breakup by Product||Immunosuppressants, Immunostimulants|
|Breakup by Application||Oncology, Respiratory, HIV, Others|
|Breakup by Region||North America, Europe, Asia Pacific, Latin America, Middle East and Africa|
|Market Dynamics||SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand|
|Competitive Landscape||Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications|
|Companies Covered||F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Novartis AG, Biogen Inc., Others|
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
7 Industry Opportunities and Challenges
8 Global Immunomodulators Market Analysis
8.1 Key Industry Highlights
8.2 Global Immunomodulators Historical Market (2017-2021)
8.3 Global Immunomodulators Market Forecast (2022-2027)
8.4 Global Immunomodulators Market by Product
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2017-2021)
188.8.131.52 Forecast Trend (2022-2027)
184.108.40.206 Breakup by Products
220.127.116.11.1.1 Market Share
18.104.22.168.1.2 Historical Trend (2017-2021)
22.214.171.124.1.3 Forecast Trend (2022-2027)
126.96.36.199.2 Calcineurin Inhibitors
188.8.131.52.2.1 Market Share
184.108.40.206.2.2 Historical Trend (2017-2021)
220.127.116.11.2.3 Forecast Trend (2022-2027)
18.104.22.168.3.1 Market Share
22.214.171.124.3.2 Historical Trend (2017-2021)
126.96.36.199.3.3 Forecast Trend (2022-2027)
188.8.131.52.4.1 Market Share
184.108.40.206.4.2 Historical Trend (2017-2021)
220.127.116.11.4.3 Forecast Trend (2022-2027)
18.104.22.168 Market Share
22.214.171.124 Historical Trend (2017-2021)
126.96.36.199 Forecast Trend (2022-2027)
188.8.131.52 Breakup by Product
184.108.40.206.1.1 Market Share
220.127.116.11.1.2 Historical Trend (2017-2021)
18.104.22.168.1.3 Forecast Trend (2022-2027)
22.214.171.124.2.1 Market Share
126.96.36.199.2.2 Historical Trend (2017-2021)
188.8.131.52.2.3 Forecast Trend (2022-2027)
8.5 Global Immunomodulators Market by Application
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2017-2021)
18.104.22.168 Forecast Trend (2022-2027)
22.214.171.124 Market Share
126.96.36.199 Historical Trend (2017-2021)
188.8.131.52 Forecast Trend (2022-2027)
184.108.40.206 Market Share
220.127.116.11 Historical Trend (2017-2021)
18.104.22.168 Forecast Trend (2022-2027)
8.6 Global Immunomodulators Market by Region
8.6.1 Market Share
22.214.171.124 North America
126.96.36.199 Asia Pacific
188.8.131.52 Latin America
184.108.40.206 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
220.127.116.11 United States of America
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
18.104.22.168 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
22.214.171.124 Saudi Arabia
126.96.36.199 United Arab Emirates
188.8.131.52 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 F. Hoffmann-La Roche Ltd.
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.2 Amgen, Inc.
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.3 Abbott Laboratories
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
11.2.4 Novartis AG
22.214.171.124 Company Overview
126.96.36.199 Product Portfolio
188.8.131.52 Demographic Reach and Achievements
11.2.5 Biogen Inc.
184.108.40.206 Company Overview
220.127.116.11 Product Portfolio
18.104.22.168 Demographic Reach and Achievements
12 Industry Events and Developments
Additional Customisations Available
1 Manufacturing Process
1.2 Detailed Process Flow
1.3 Operation Involved
2 Project Requirement and Cost Analysis
2.1 Land, Location and Site Development
2.3 Plant Machinery
2.4 Cost of Raw Material
2.9 Other Capital Investment
List of Figures and Tables
1. Global Immunomodulators Market: Key Industry Highlights, 2016 and 2026
2. Global Immunomodulators Historical Market: Breakup by Product (USD Million), 2017-2021
3. Global Immunomodulators Market Forecast: Breakup by Product (USD Million), 2022-2027
4. Global Immunomodulators Historical Market: Breakup by Application (USD Million), 2017-2021
5. Global Immunomodulators Market Forecast: Breakup by Application (USD Million), 2022-2027
6. Global Immunomodulators Historical Market: Breakup by Region (USD Million), 2017-2021
7. Global Immunomodulators Market Forecast: Breakup by Region (USD Million), 2022-2027
8. North America Immunomodulators Historical Market: Breakup by Country (USD Million), 2017-2021
9. North America Immunomodulators Market Forecast: Breakup by Country (USD Million), 2022-2027
10. Europe Immunomodulators Historical Market: Breakup by Country (USD Million), 2017-2021
11. Europe Immunomodulators Market Forecast: Breakup by Country (USD Million), 2022-2027
12. Asia Pacific Immunomodulators Historical Market: Breakup by Country (USD Million), 2017-2021
13. Asia Pacific Immunomodulators Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Latin America Immunomodulators Historical Market: Breakup by Country (USD Million), 2017-2021
15. Latin America Immunomodulators Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Middle East and Africa Immunomodulators Historical Market: Breakup by Country (USD Million), 2017-2021
17. Middle East and Africa Immunomodulators Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Global Immunomodulators Market Structure
In 2020, the global immunomodulators market attained a value of nearly USD 175 billion.
The market is projected to grow at a CAGR of 5.8% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 245 billion by 2026.
The market is being driven by the prevailing cases of organ transplantation that boosts the demand for immunomodulator drugs, growing geriatric population, and rising incidence of chronic diseases.
The key industry trend that is influencing the market growth includes the combination of antigen and immunomodulators as it targets the pathways that treat multiple diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The different products of immunomodulators available in the industry are immunosuppressants and immunostimulants.
The major applications of immunomodulators are oncology, respiratory, and HIV, among others.
The major players in the industry are F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Novartis AG, and Biogen Inc., among others.
The global immunomodulators market attained an approximate value of USD 175 billion in 2020, driven by the rising prevalence of awareness among the masses regarding immunomodulators. Aided by the rising chronic diseases, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 5.8%. The market is projected to reach nearly USD 245 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the immunomodulators industry can be segmented into immunosuppressants and immunostimulants. On the basis of application, the market is categorised into oncology, respiratory, and HIV, among others. The major regional markets for immunomodulators are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Novartis AG, and Biogen Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.